Featured News

MIA’s Ayurdhi Dhar interviews Sunil Bhatia about decolonizing psychology, confronting the field’s racist past, colonial foundations, and neoliberal present.

Psychiatrists argue that current practice fails to account for the interaction of biological, psychosocial and iatrogenic factors.

Neuropsychological assessments reveal the cognitive, occupational, and social impact of polypharmacy in psychiatry.

MIA’s Ayurdhi Dhar interviews Ian Parker about critical psychology, discourse and political action, and whether psychology has anything left to offer.

A new review of antipsychotic trials conducted over the last 24 years finds that the placebo response rate is steadily increasing, and drug response is decreasing.

A network analysis of participants’ social media use and well-being reveals complex links with social capital but a minimal association with attentional control.

Researchers at Johns Hopkins test paroxetine on developing brain cells and discover numerous neurotoxic effects.

New study finds that Medicaid enrolled youth were 14 times more likely to be on an antidepressant in 2014 than in 1987.

Researchers suggest that the pharmaceutical industry had a vested interest in using the term “discontinuation” in order to hide the severity of physical dependence and withdrawal reactions many people experience from antidepressants.

In the first systematic review of withdrawal problems that patients experience when trying to get off SSRI antidepressant medications, researchers found that withdrawing from SSRIs was comparable to trying to quit addictive benzodiazepines.

A new survey exploring antipsychotic user experience finds that more than half of the participants report only negative experiences.

Researchers confirm that the suicide warning for antidepressants is justified by the evidence and that claims that the warning is harmful lack support.

Selective serotonin reuptake inhibitors (such as Prozac and Zoloft) are the most commonly prescribed medication for depression. SSRIs have long been associated with an...

The alternative treatment model of Soteria helps individuals suffering from schizophrenia without relying on medication or coercion.

A new study, published in the JAMA Psychiatry, investigates the effect of stimulant ‘ADHD’ drugs on the brains of children and young adults. The...

Throughout the past two decades, studies have warned of increased suicide rates in those taking antidepressants, especially in children and adolescents. Researchers also documented...

A large study of the population in Taiwan reveals that long-term use of benzodiazepine drugs, commonly prescribed for anxiety, significantly increases the risk for brain, colorectal, and lung cancers. The research, published open-access in the journal Medicine, also identifies the types of benzodiazepines that carry the greatest cancer risk.

A new study suggests that taking antidepressants impairs empathy, while the experience of depression itself does not.

UN official writes that States should focus instead on resolving social inequality and injustice as determinants of health and human rights.

New study finds that people who felt they were coerced into being hospitalized were more likely to attempt suicide later.

A new article reviews studies in the field of nutritional psychiatry and how nutrition can prevent and treat mental health issues.

A new update to the NICE guideline for depression suggests providers discuss long-term, severe antidepressant withdrawal symptoms.

A new systematic review finds that patients report reduced symptoms but also loss of self and agency while taking antipsychotics.

An issue of Lancet Psychiatry is devoted to clarifying the lack of efficacy for Zoloft (sertraline).

New research counters the long-held assumption that a longer duration of untreated psychosis is associated with worse outcomes.